Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP) — Stella

Recruiting

Back to Transient; Hypoglycemia, Neonatal trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

France

Hopital Necker - Enfants malades, Paris

Key details

Phase

Safety & dosing

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

URC-CIC Paris Descartes Necker Cochin

Enrollment target

~35 participants

Started

May 2023

Primary completion

November 2026

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov